Tranche Update on Huapont Life Sciences Co., Ltd.'s Equity Buyback Plan announced on April 4, 2018.
January 03, 2019
Share
From October 1, 2018 to December 31, 2018, the company has repurchased 21,143,923 shares, representing 1.06% for CNY 103.23 million. With this, the company has completed the repurchase of 54,010,494 shares, representing 2.74% for CNY 289.05 million under the buyback announced on April 4, 2018.
HUAPONT LIFE SCIENCES CO., LTD. is a China-based company principally engaged in the research and development, manufacture and sales of pesticide chemical products. The Company operates through three segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sales of skin pharmaceuticals, antituberculous pharmaceuticals and other manufactured products. Its products include fleroxacin and ambroxol hydrochloride for injection, and lecithin-bound iodine capsules, among others. The Pesticide Chemical segment is engaged in the production and sales of pesticides and other fine chemicals, including herbicides, bactericides and insecticides, among others. The Bulk Drug segment is engaged in the research and development and manufacture of bulk drugs and medical intermediates. The Company is also engaged in the provision of travel services, the sales of tea and the provision of technical services, among others.
HUAPONT LIFE SCIENCES CO.,LTD 
